Tech Company Financing Transactions
VarmX Funding Round
VarmX, based in Leiden, secured $2.2 billion in investment from EQT Life Sciences.
Transaction Overview
Company Name
Announced On
9/16/2025
Transaction Type
Venture Equity
Amount
$2,200,000,000
Round
Undisclosed
Investors
EQT Life Sciences (John de Koning)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Middelweg 38 B
Leiden, 2312 KJ
NL
Leiden, 2312 KJ
NL
Phone
Undisclosed
Website
Email Address
Overview
VarmX is a spin-off from the Leiden University Medical Center (LUMC). The mission of VarmX is to develop and manufacture therapeutic proteins to restore hemostasis. VarmX's lead compound VMX-COO1 is intended to safely and effectively restore hemostasis in case of bleeding or emergency surgery in patients taking so-called oral factor Xa inhibitors. Synthetic oral factor Xa inhibitors (such as edoxaban, rivaroxaban and apixaban) belong to the latest generation of anticoagulants and their world-wide use by patients at risk of thrombosis and stroke is increasing rapidly. However, usage of factor Xa inhibitors comes at the expense of a risk of uncontrolled and potentially life-threatening bleeding. To stop or prevent - the latter in the case of emergency surgery - these bleedings one needs a reversal agent as an antidote. VarmX has a product in its pipeline called VMX-COO1 that promises safe and effective reversal.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jan Öhrström
Chief Financial Officer
Paul Roos
Chief Scientific Officer
Jeffrey Lawson
Browse more venture capital transactions:
Prev: 9/16/2025: Nofence venture capital transaction
Next: 9/16/2025: itselectric venture capital transaction
Share this article
News on VC Transactions
We record all VC transactions involving tech companies. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs